Avid Bioservices Inc (CDMO)

[dia76ca]

It sounds to me that we will be getting some interim first line NSCLC data on Nov.1. We don't know when the breast cancer data will be published. We were told by the investigator that there would be interim liver cancer data presented "this year". And we could hear from the "dozens" of collaborations at any time. Partnering could be announced before or after any trial data is released.

It is a good thing that biotech investors are patient people. All trials take a long time...and those that produce outstanding MOS results take even longer than usual. And partnering can be a long dance...particularly if there is more than one potential partner...which I think is the case with the anti-PS technology.